*ST大药
(603963)
| 流通市值：2.59亿 | | | 总市值：2.59亿 |
| 流通股本：2.20亿 | | | 总股本：2.20亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2025-12-31 | 2025-06-30 | 2024-12-31 |
| 营业总收入 | 41,531,147.55 | 99,205,241.74 | 53,112,353.93 | 67,764,057.45 |
| 营业总成本 | 52,748,273.19 | 121,753,527.45 | 65,657,917.07 | 98,026,449.2 |
| 其他经营收益 | | | | |
| 营业利润 | -11,383,734.45 | -19,555,275.37 | -12,595,335.34 | -29,605,874.55 |
| 利润总额 | -11,175,766.81 | -19,460,656.3 | -12,554,459.36 | -29,279,091.59 |
| 净利润 | -11,212,798.81 | -19,470,698.07 | -12,584,135.98 | -33,638,546.9 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | -11,212,798.81 | -19,470,698.07 | -12,584,135.98 | -33,638,546.9 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2025-12-31 | 2025-06-30 | 2024-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 194,724,769.95 | 211,289,539.96 | 213,230,109.58 | 254,647,259.57 |
| 非流动资产: | | | | |
| 非流动资产合计 | 159,496,907.5 | 162,318,363.37 | 167,060,369.69 | 171,019,906.28 |
| 资产总计 | 354,221,677.45 | 373,607,903.33 | 380,290,479.27 | 425,667,165.85 |
| 流动负债: | | | | |
| 流动负债合计 | 36,146,538.48 | 45,381,048.45 | 45,072,140.41 | 76,758,654.54 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,272,197.79 | 211,114.89 | 316,036.78 | 1,422,073.25 |
| 负债合计 | 37,418,736.27 | 45,592,163.34 | 45,388,177.19 | 78,180,727.79 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 316,802,941.18 | 328,015,739.99 | 334,902,302.08 | 347,486,438.06 |
| 股东权益合计 | 316,802,941.18 | 328,015,739.99 | 334,902,302.08 | 347,486,438.06 |
| 负债和股东权益合计 | 354,221,677.45 | 373,607,903.33 | 380,290,479.27 | 425,667,165.85 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2025-12-31 | 2025-06-30 | 2024-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 37,246,063.57 | 103,768,226.39 | 47,609,485.57 | 73,576,907.58 |
| 经营活动现金流出小计 | 49,663,177.43 | 111,364,470.32 | 52,224,661.94 | 95,452,644.51 |
| 经营活动产生的现金流量净额 | -12,417,113.86 | -7,596,243.93 | -4,615,176.37 | -21,875,736.93 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | - | 15,822 | - | 329,570,142.08 |
| 投资活动现金流出小计 | 508,212 | 5,674,578.4 | 5,123,410.4 | 122,794,094.92 |
| 投资活动产生的现金流量净额 | -508,212 | -5,658,756.4 | -5,123,410.4 | 206,776,047.16 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | - |
| 筹资活动现金流出小计 | 848,847.01 | 14,886,396.99 | 14,886,396.99 | 10,459,989.36 |
| 筹资活动产生的现金流量净额 | -848,847.01 | -14,886,396.99 | -14,886,396.99 | -10,459,989.36 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -13,774,172.87 | -28,141,397.32 | -24,624,983.76 | 174,440,320.87 |
| 期末现金及现金等价物余额 | 146,718,739.4 | 160,492,912.27 | 164,009,325.83 | 188,634,309.59 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -13,774,172.87 | -28,141,397.32 | -24,624,983.76 | 174,440,320.87 |